Next Gen Cannabinoids for Clinical Neurology
Renew Biopharma employs synthetic biology to create custom enzymes that produce novel molecules that cross the blood brain barrier, and target specific receptors associated with neuroinflammation and chronic pain.

Who We Are

Renew employs rational enzyme engineering to modify and improve enzymes to create and manufacture novel molecules.  This allows us to design these molecules for potency and efficacy for specific, targeted indications.

Learn More

Key Strengths

RENEW’S UNMATCHED ABILITIES ARE ATTRIBUTED TO THREE KEY FACTORS:

Decades of scientific and business leadership in biotechnology

Synthetic biology platform coupled with rational enzyme engineering

Leveraging a portfolio of intellectual property including licensed issued patents and robust new pending patents

Our Mission

To harness microbial synthetic biology for the purpose of improving human health.

Our Goal

To produce proprietary alkylresorcinol-scaffold derivatives that lead to powerful new therapeutics for neuroinflammatory diseases.

Next Gen Cannabinoids for Clinical Neurology

Contact Us

General Inquiries: info@renewbiopharma.com

Press Inquiries: press@renewbiopharma.com

Contact Us